In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

TherapeuticsMD, Inc.. Trade Record

AMEX:TXMD TherapeuticsMD, Inc. stock gains 22.07% Exit Jan 28, 2019 a Trade Record by priceseries

Trade Chart
Trade Chart TXMD Jan 4, 2019, priceSeries
About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. operates as a women's health care product company. The company manufactures and distributes prescription and over-the-counter product lines, including prenatal vitamins, iron supplements, and natural menopause relief products under the vitaMedMD brand, as well as generic formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. Its pipeline of hormone therapy drug candidates include TX-001HR, a combination of estradiol and progesterone drug candidate under clinical trials for the treatment of moderate to severe vasomotor symptoms due to menopause; TX-002HR, a natural progesterone formulation for the treatment of secondary amenorrhea without the potentially allergenic component of peanut oil; and TX-004HR, an applicator-free vaginal estradiol softgel drug candidate for the treatment of vulvar and vaginal atrophy in post-menopausal women with vaginal linings that do not receive enough estrogen. The company markets its products primarily through a direct national sales force to health care providers in the OB/GYN market space. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Trade Information
Trade Type
LONG
ReliabilityScore™
82.76
Entry Date
Jan 4, 2019
Entry Price
4.17
Sell Date
Jan 28, 2019
Sell Price
5.09
Net Gain
22.07%
Hold Time
15 Trading Days